Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Heuser

Showing results (111-120 of 280) with videos related to

Pageof 28
Sort By:
Human Gene Therapy|February 9, 2019
Preclinical Assessment of Suitable Natural Killer Cell Sources for Chimeric Antigen Receptor Natural Killer-Based "Off-the-Shelf" Acute Myeloid Leukemia ImmunotherapiesStephan Kloess, Olaf Oberschmidt, Julia Dahlke, et al.
Blood|December 9, 2008
High-affinity neurotrophin receptors and ligands promote leukemogenesisZhixiong Li, Gernot Beutel, Mathias Rhein, et al.
British Journal of Haematology|March 31, 2015
A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating FLT3 mutationsWalter Fiedler, Sabine Kayser, Maxim Kebenko, et al.
Blood|August 12, 2009
Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewalMichael Heuser, Laura M Sly, Bob Argiropoulos, et al.
Blood Advances|January 20, 2022
Reduced intensity hematopoietic stem cell transplantation for accelerated-phase myelofibrosisNico Gagelmann, Christine Wolschke, Rachel B Salit, et al.
Blood|May 15, 2007
MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AMLMichael Heuser, Bob Argiropoulos, Florian Kuchenbauer, et al.
Blood|April 28, 2010
Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemiaFelicitas Thol, Frederik Damm, Katharina Wagner, et al.
British Journal of Haematology|June 10, 2020
A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemiaWalter Fiedler, Joerg Chromik, Stefanie Amberg, et al.
International Journal for Equity in Health|July 7, 2026
Heat exhaustion, domestic heat exposure and socioeconomic disparities among older adults: a cross-sectional mediation analysis from GermanyCatherina Heinken, Saskia Muellmann, Tilman Brand, et al.
European Journal of Haematology|September 24, 2017
Clinical impact of KMT2C and SPRY4 expression levels in intensively treated younger adult acute myeloid leukemia patientsSabine Kayser, Maximilian Feszler, Julia Krzykalla, et al.
Pageof 28

Showing results (111-120 of 280) with videos related to

Sort By:
Pageof 28
Human Gene Therapy|February 9, 2019
Preclinical Assessment of Suitable Natural Killer Cell Sources for Chimeric Antigen Receptor Natural Killer-Based "Off-the-Shelf" Acute Myeloid Leukemia ImmunotherapiesStephan Kloess, Olaf Oberschmidt, Julia Dahlke, et al.
Blood|December 9, 2008
High-affinity neurotrophin receptors and ligands promote leukemogenesisZhixiong Li, Gernot Beutel, Mathias Rhein, et al.
British Journal of Haematology|March 31, 2015
A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating FLT3 mutationsWalter Fiedler, Sabine Kayser, Maxim Kebenko, et al.
Blood|August 12, 2009
Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewalMichael Heuser, Laura M Sly, Bob Argiropoulos, et al.
Blood Advances|January 20, 2022
Reduced intensity hematopoietic stem cell transplantation for accelerated-phase myelofibrosisNico Gagelmann, Christine Wolschke, Rachel B Salit, et al.
Blood|May 15, 2007
MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AMLMichael Heuser, Bob Argiropoulos, Florian Kuchenbauer, et al.
Blood|April 28, 2010
Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemiaFelicitas Thol, Frederik Damm, Katharina Wagner, et al.
British Journal of Haematology|June 10, 2020
A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemiaWalter Fiedler, Joerg Chromik, Stefanie Amberg, et al.
International Journal for Equity in Health|July 7, 2026
Heat exhaustion, domestic heat exposure and socioeconomic disparities among older adults: a cross-sectional mediation analysis from GermanyCatherina Heinken, Saskia Muellmann, Tilman Brand, et al.
European Journal of Haematology|September 24, 2017
Clinical impact of KMT2C and SPRY4 expression levels in intensively treated younger adult acute myeloid leukemia patientsSabine Kayser, Maximilian Feszler, Julia Krzykalla, et al.
Pageof 28